Probi
185 SEK -2,12 %Vær den første som følger denne virksomhed
Probi is a biotechnology company. The company is particularly focused on the research and development of probiotics, a bacterium that is found in the human intestinal system. The research areas within the company include the gastrointestinal, immune system, metabolic syndrome, and stress and recovery. The company's customers include larger corporate customers active in the food industry. The company was founded in 1991 and is headquartered in Lund.
Omsætning
618,29 mio.
EBIT %
8,18 %
P/E
51,82
Udbytteafkast, %
0,7 %
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
PROB
Daglig lav / høj pris
179,5 / 189
SEK
Markedsværdi
2,11 mia. SEK
Aktieomsætning
420,72 t SEK
Volumen
2,3 t
Seneste videoer
Finanskalender
Delårsrapport
18.07.2023
Delårsrapport
24.10.2023
Årsrapport
26.01.2024
Viser Alle indholdstyper
